Aphria: Consensus Estimates For Q3 2021

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expected to report their fiscal third quarter on April 12th. Analysts have a consensus C$17.72 12-month price target on the company, via a total of ten analysts, with two analysts have strong buy ratings. Five analysts have buy ratings and three have hold ratings. The street high comes from Cantor Fitzgerald with a C$32.50 price target, and the lowest target comes is a C$7 price target.

Seven analysts have revenue estimates for the third quarter. The mean between all 7 is C$170.66 million; this number has been revised downwards from C$175.58 million at the start of the year. The highest revenue estimate is C$182.90 million, while the lowest is C$152 million.

Onto EBITDA estimates, there are currently seven analysts who have third-quarter EBITDA estimates. The mean is currently C$14.46 million, with this number having been revised down from C$18.97 million at the start of the year. Street high is C$21.70 million EBITDA estimate and the lowest being C$6 million.

Analysts estimate that quarterly earnings per share will come in at negative C$0.03, with this number being revised down from negative C$0.01 at the start of the year. Street high is break-even and the lowest estimate is negative C$0.05 for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Golden Cariboo’s First Quesnelle Resource Estimate Tallies 1.19 Million Gold Equivalent Ounces

Brixton Wraps Camp Creek Drilling With 17.58 Metres of 1.47 g/t Gold Equivalent

Related News

Cineplex: Canaccord Lowers Target To $17 From $19

On February 11th, Cineplex Inc (TSX: CGX) reported its fourth quarter financial results. The company...

Tuesday, February 15, 2022, 05:17:00 PM

Liberty Health Sciences Sells Florida Greenhouse, Land and Ohio Assets for $14.75M

Tonight Liberty Health Science (CSE: LHS) announced the Company is selling 36 acres of land,...

Monday, August 19, 2019, 11:48:31 PM

Alphabet: BMO Lowers Estimates Ahead Of Earnings Release Tomorrow

Alphabet (NASDAQ: GOOGL) announced that it will be reporting its quarterly financial results on October...

Monday, October 25, 2021, 10:06:00 AM

PharmaTher: Maxim Initiates Coverage With US$1.50 Price Target

PharmaTher Holdings (CSE: PHRM) had its first initiation report that came out on June 28th....

Wednesday, June 30, 2021, 02:38:00 PM

Curaleaf: Consensus Estimate Fourth Quarter Earnings Preview

Curaleaf Holdings (CSE: CURA) announced that they will be reporting their fourth quarter and year-end...

Tuesday, March 9, 2021, 12:26:00 PM